Early research (Phase 1)Ended earlyNCT04271306
What this trial is testing
Safety, Immunogenicity and ex Vivo Efficacy of Pfs25-IMX313/Matrix-M in Healthy Volunteers in Bagamoyo, Tanzania.
Who this might be right for
Malaria,Falciparum
University of Oxford 34